[ Price : $8.95]
Omni Bio Pharmaceutical reports the first patient has been infused with Alpha-1 antitrypsin in an FDA-cleared Phase 1/2 clinical t...[ Price : $8.95]
Federal Register Notice: FDA sends a proposed collection of information on testing communications on medical devices and radiation...[ Price : $8.95]
Federal Register Notice: FDA extends to 11/1 the comment period on the agencys medical device user fee program and the next reauth...[ Price : $8.95]
FDA approves ISTA Pharmaceuticals Bromday bromfenac solution for what the company says is the first once-daily Rx eye drop for pos...[ Price : $8.95]
McNeil Consumer Healthcare recalls one lot of Tylenol 8 Hour caplets 50 count bottles after receiving complaints of a musty or mol...[ Price : $8.95]
CDERs Office of New Drugs publishes a MAPP on proper use of clinical source data to audit applicants endpoint adjudication process...[ Price : $8.95]
FDA publishes a guidance to help IND sponsors know what chemistry, manufacturing, and control information should be submitted in a...[ Price : $8.95]
FDA grants fast track status to Aastrom Biosciences for its critical limb ischemia cell therapy development program.